Oct 2026· European journal of medicinal chemistry· Vol 321 Pt 2, pp.
119384
· 0 citations· 25 references
Medicine
TL;DR
The design and evaluation of analogues aimed at improving metabolic stability while defining the structural features required for antibacterial activity are described and key insights that may aid in identifying the compound's molecular target are provided.
Abstract
A 1,3,4-oxadiazole-based compound named 1771 and its derivatives have been reported to exhibit antibacterial activity against Gram-positive bacteria, with activity extending to Gram-negative pathogens upon disruption of the outer membrane permeability barrier and/or efflux pump systems. However, the precise mode of action of these compounds remains unknown, and their utility is limited by low metabolic stability. Here, we describe the design and evaluation of analogues aimed at improving metabolic stability while defining the structural features required for antibacterial activity. Structure activity relationship analysis identified the secondary amide and the phenyl group as essential for antibacterial activity. Introduction of a para-pentafluorosulfanyl (SF5) substituent yielded compound 9b, which showed improved antibacterial potency and microsomal stability when compared to 1771. Although 9b remained suboptimal in microsomal stability, it provided the best overall balance of antibacterial activity and metabolic profile. Overall these results define key structural requirements for activity and provide a foundation for further optimization of this oxadiazole-based antibacterial scaffold, while providing key insights that may aid in identifying the compound's molecular target.
The presence of fungistatic properties and potential resistance issues associated with current azole drugs have created a growing demand for discovering novel antifungal agents without these negative attributes. This study introduces the synthesis of a unique series of 4-(5-(benzylthio)-1,3,4-oxadiazol-2-yl) phenol der...
Mohammad Shafiei, Sara Masoudinia, Mahfam Moradi et al.· RSC Advances· 0 citations
The synthesis and evaluation of novel bis-triazole derivatives, designed to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization, provide a basis for further optimization of triazole-based antimicrobial agents.
Ahmed M. Abobakr, Rasha A. Nabil, H. H. Temirek et al.· Polycyclic aromatic compound...· 0 citations
The available evidence demonstrates the remarkable therapeutic versatility of 1,3,4-oxadiazole–sulfonamide hybrids and supports their continued exploration as promising scaffolds for future drug discovery and development.
Alshaimaa Hosney, Elshimaa M. N. Abdelhafez, Mamdouh F. A. Mohamed· RSC Advances· 0 citations
The data suggest para-methoxy substitution improves antibacterial activity, meriting further studies on solubility enhancement, metabolic stability and in vivo validation.
Ankit Goel, K. Yadav, Tanya Jain et al.· Oriental Journal of Chemistr...· 0 citations
Findings designate 6i as a prospective candidate exhibiting significant antibacterial, antibiofilm, and host-directed immunomodulatory activities for the treatment of multidrug-resistant bacterial illnesses for the treatment of multidrug-resistant bacterial illnesses.
Bandi Muralikrishna, N. Sateesh, Rambabu Palabindela et al.· RSC Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.